期刊文献+

介入治疗对冠状动脉临界病变患者近远期预后的影响研究 被引量:7

暂未订购
导出
摘要 目的比较介入治疗与药物治疗冠状动脉临界病变的非急性心肌梗死冠心病的预后。方法根据经皮冠状动脉介入治疗(PCI)结合药物治疗方法与单纯药物治疗这两种治疗方法,将220例冠脉临界病变的非急性心肌梗死冠心病患者分为PCI组112例(药物治疗基础上PCI)与药物组108例。比较两组患者随访期间的心脏不良事件,主要记录再发心绞痛、心律失常、心肌梗死、心力衰竭、死亡以及是否靶血管需要再次介入治疗情况。结果患者的平均随访时间是(15.2±4.6)个月。随访期间,PCI组再发心绞痛发生的比例(55.4%)明显高于药物组(32.4%),χ2=11.747,P=0.001;PCI组需要再次介入治疗的比例(31.2%)也明显高于药物组(13.0%),χ2=10.621,P=0.001;PCI组心力衰竭的发生比例(18.8%)也明显高于药物组的(9.3%),χ2=4.091,P=0.043。在心律失常、心肌梗死、死亡事件的发生比例上PCI组与药物组的差异无统计学意义(P>0.05)。结论 PCI治疗的主要心脏不良事件发生率高,与药物治疗相比,PCI治疗冠状动脉临界病变并无明显的优势。
出处 《检验医学与临床》 CAS 2014年第9期1219-1220,共2页 Laboratory Medicine and Clinic
基金 湖北省孝感市科技局资助项目(2012652)
  • 相关文献

参考文献9

  • 1陈纪林,延荣强.冠状动脉临界病变介入治疗的新思路[J].中国循环杂志,2013,28(2):81-82. 被引量:11
  • 2Manoharan G, Ntalianis A, Muller O, et al. Severity of coronary arterial stenoses responsible for acute coronary syndromes[J]. Am J Cardiol,2009,103(9) : 1183-1188.
  • 3Kramer MC, Verouden NC, Li X, et al. Thrombus aspira- tion alone during primary percutanous coronary interven- tion as definitive treatment in acute ST-elevation myocar- dial infarction [J]. Catheter Cardiovasc Interv, 2012, 79 (6) :860-867.
  • 4Pijls NH, Sels JW. Functional measurement of coronary stenosis[J]. J Am Coll Cardiol, 2012,59 (12) : 1045-1057.
  • 5Tanaka S, Noda T, Segawa T, et al. Relation between functional stenosis and tissue characterization of interme- diate coronary plaques in patients with stable coronary heart disease[J]. J Cardiol,2010,55(3) :296-302.
  • 6Chaitman BR, Hartigan PM, Booth DC, et al. Do major cardiovascular outcomes in patients with stable ischemic heart disease in the clinical outcomes utilizing revascular- ization and aggressive drug evaluation trial differ by healthcare system[J]. Circ Cardiovasc Qual Outcomes, 2010,3(5) :476-483.
  • 7于宏梅,金惠根,赵德强,刘宗军,王大英,郜俊清.冠状动脉临界病变介入与药物治疗的预后比较[J].上海医学,2011,34(6):452-454. 被引量:5
  • 8康铁朵,吕树铮,刘文娴,宁尚秋,李江,熊然.主动脉内球囊反搏置入时机对高危冠脉介入术患者预后的影响及相关因素分析[J].河北医药,2013,35(8):1166-1168. 被引量:4
  • 9袁勇,李明星,冯力,董剑廷,孙艳香,张励庭,黄炫生,韩莹,邓志华.冠状动脉临界病变行介入治疗预后的临床观察[J].临床心血管病杂志,2013,29(5):338-340. 被引量:5

二级参考文献33

  • 1王涛,潘家华,喻卓.主动脉内球囊反搏在高危冠心病中的应用[J].国际心血管病杂志,2006,33(3):163-166. 被引量:13
  • 2TOBIS J, AZARBAL B, SLAVIN I.. Assessment of intermediate severity coronary lesions in the catheterization laboratory[J]. J Am Coil Cardiol, 2007, 49:839-848.
  • 3LEE C H. Intravascular Ultrasound Guided PercutaneousCoronary Intervention: A Practical Approach [J]. J Interv Cardiol, 2011 May 3. [Epub ahead of print].
  • 4LINDSTAEDT M, HALILCAVUSOGULLARI Y, YAZAR A, et al. Clinical outcome following conservative vs revascularization therapy in patients with stable coronary artery disease and borderline fractional flow reserve measurements [J]. Clin Cardiol, 2010, 33: 77-83.
  • 5UCHIDA T, POPMA J, STONE G W, et al. The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions [J]. JACC Cardiovasc Interv, 2010, 3 : 403-411.
  • 6LEGUTKO J, DUDEK D, CHYRCHEL M, et al. Safety and effectiveness of pharmacologic versus mechanical stabilization of borderline coronary lesions in patients with acute coronary syndromes [J]. Przegl Lek, 2005, 62:1-7.
  • 7CHAITMAN B R, HARTIGAN P M, BOOTH D C, et al. Do major cardiovascular outcomes in patients with stable ischemie heart disease in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial differ by healthcare system [J]. Circ Cardiovasc Qual Outcomes, 2010, 3:476-483.
  • 8LESPERANCE J, THEROUX P, HUDON G, et al. A new look at coronary angiograms: plaque morphology as a help to diagnosis and to evaluate outcome [J]. Int J Card Imaging, 1994, 10: 75-94.
  • 9RZECZUCH K, SZAJN G, JANKOWSKA E, et al. Borderline coronary lesions may lead to serious coronary events-long-term outcome in 65 conservatively treated patients [J]. Kardiol Pol, 2005, 63:50 57.
  • 10MAGNI V, CHIEFFO A, COLOMBO A. Evaluation of intermediate coronary stenosis with intravascular ultrasound and fractional flow reserve: Its use and abuse[J].Catheter Cardiovasc Interv, 2009, 73:441-448.

共引文献19

同被引文献58

  • 1杨璇,李玉,李长江,冯磊.GDF-15与心肌梗死后心室重塑指标的相关性[J].中国老年学杂志,2015,35(1):59-60. 被引量:12
  • 2李春慧.洛汀新与缬沙坦对老年急性心肌梗死患者心室重塑及心功能的影响[J].中国老年学杂志,2015,35(1):82-84. 被引量:17
  • 3EitelI,DeschS,deWahaS,etal.Sexdifferencesinmyo-cardialsalvageandclinicaloutcomeinpatientswithacutereperfusedST-elevationmyocardialinfarction:advancesincardiovascularimaging[J].CircCardiovascImaging,2012,5(1):119-126.
  • 4JacksonEA,MoscucciM,SmithDE,etal.Theassociationofsexwithoutcomesamongpatientsundergoingprimaryper-cutaneouscoronaryinterventionforSTelevationmyocardialinfarctioninthecontemporaryera:Insightsfrom theBlueCrossBlueShieldofMichiganCardiovascularConsortium(BMC2)[J].AmHeartJ,2011,161(1):106-112.
  • 5Gollop ND, Dhullipala A, Nagrath N, et al . Is periprocedur- al CK-MB a better indicator of prognosis after emergency and elective percutaneous coronary intervention compared with post-procedural cardiac troponins [J] Interact Cardiovasc Thorac Surg , 2013,17(5) :867-871.
  • 6Trieoci P, Leonardi S, White J, et al . Cardiac troponin after pereutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using sys- tematic evaluation of biomarker trends [J]. J Am Coll Cardiol, 2013,62(3) :242-251.
  • 7Levine G N, Bates E R, Blankenship J C, et al. 2011 ACCF/A- HA/SCAI Guideline for Percutaneous Coronary Intervention: ex- ecutive summary: a report of the American College of CardiologyFoundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J]. Catheter Cardiovasc Interv, 2012, 79(3): 453-495.
  • 8Legutko Jacek, Dudek Dariusz, Chyrchel Micha4, et al. Safety and effectiveness of pharmacologic versus mechanical stabiliza- tion of borderline coronary esions in patients with acute coronary syndromes[J].Przeglad Lekarski, 2005,62 ( 1 ): 1-7.
  • 9Rzeczuch Krzysztof, Szajn Grzegorz, Jankowska Ewa, et al. Bor- derline coronary lesions may lead to serious coronary events-long-term outcome in 65 conservatively treated pa- tients[J]. Kardiologia Polska, 2005, 63 (7):50-56.
  • 10Stone G W, Ellis S G, Cox D A, et al. One-year clinical results with the slow-release, polymer-based, paciitaxel-eluting TAXUS stent: the TAXUS-IV trial[J],Circulation, 2004,109(16): 1942-1947.

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部